Ectopic pregnancy
153 results
101 - 153
Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects- Nonsteroidal anti‐inflammatory drugs for assisted reproductive technology
Tight control no different from less-tight control of hypertension in pregnancy- Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects: Cochrane systematic review
Acute abdomen in the adult - Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies
- Antioxidants for male subfertility
- Progestogens for preventing miscarriage: a network meta‐analysis
- Aspirin for in vitro fertilisation
- Surgery for tubal infertility
- Oxytocin antagonists for assisted reproduction
- Long‐term pituitary down‐regulation before in vitro fertilization (IVF) for women with endometriosis
- Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
- Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction
- Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility
- Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)
- Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction
- Chronic diseases and pregnancy
- Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility: Cochrane systematic review
- Endometriosis
- Progesterone does not prevent recurrent miscarriage (PROMISE)
- Autologous platelet‐rich plasma for assisted reproduction
- Letrozole is noninferior to mifepristone for the management of missed miscarriage
- Infertility
- Postoperative procedures for improving fertility following pelvic reproductive surgery: Cochrane systematic review
- Gonadotropins for ovulation induction in women with polycystic ovary syndrome
- Granulocyte‐colony stimulating factor administration for subfertile women undergoing assisted reproduction
- Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
- Pelvic inflammatory disease (PID)
- Surgical treatment for tubal disease in women due to undergo in vitro fertilisation
- Peri‐implantation glucocorticoid administration for assisted reproductive technology cycles
- Antibiotic therapy for pelvic inflammatory disease
- Hyaluronic acid in embryo transfer media for assisted reproductive technologies
- Abnormal menstrual bleeding
- Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility
- Laparoscopy for the management of acute lower abdominal pain in women of childbearing age: Cochrane systematic review
- The most important known health risks of smoking
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Antenatal clinics: care and examinations
- Screening for genital chlamydia infection
- Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews
- Growth hormone for in vitro fertilisation (IVF)
- Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in‐vitro fertilisation (IVF)
- Hormonal contraception
- Controlled ovarian stimulation protocols for assisted reproduction: a network meta‐analysis
- Rapid point of care test for detecting urogenital Chlamydia trachomatis infection in nonpregnant women and men at reproductive age